 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property. The term “Ren”, defined as “human”, is derived from the Chinese pinyin for “人” (rén), which integrates Eastern cultural elements and represents Biocytogen’s commitment to developing innovative technologies that advance the disco…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=974528&sourceType=rss